苯噻啶结构式
|
常用名 | 苯噻啶 | 英文名 | Pizotifen |
---|---|---|---|---|
CAS号 | 15574-96-6 | 分子量 | 295.442 | |
密度 | 1.2±0.1 g/cm3 | 沸点 | 436.7±45.0 °C at 760 mmHg | |
分子式 | C19H21NS | 熔点 | 140-142°C | |
MSDS | 中文版 美版 | 闪点 | 217.9±28.7 °C | |
符号 |
GHS07, GHS08 |
信号词 | Warning |
苯噻啶用途Pizotifen 是 5-HT2 受体的有效拮抗剂,并对 5-HT1C 有高亲和力。 |
中文名 | 苯噻啶 |
---|---|
英文名 | pizotifen |
中文别名 | 4-(9,10-二氢-4H-苯并[4,5]环庚烷并[1,2-b]噻吩-4-亚基)-1-甲基哌啶 | 新度美安 |
英文别名 | 更多 |
描述 | Pizotifen 是 5-HT2 受体的有效拮抗剂,并对 5-HT1C 有高亲和力。 |
---|---|
相关类别 | |
靶点 |
5-HT2A Receptor 5-HT1C Receptor |
体外研究 | Pizotifen是一种有效的5-HT2受体拮抗剂,对5-HT1C结合位点具有高亲和力[1]。 Pizotifen是一种抗过敏的5-HT2A受体拮抗剂,具有抑制5-羟色胺增强的ADP诱导的血小板聚集的能力[2]。 |
体内研究 | 所有给药剂量的Pipethiadene和Pizotifen都显着降低了胎儿的体重;在0.6和1.2 mg/kg Pipethiadene之后,并且仅在中等剂量的Pizotifen之后,胎盘的重量显着减少。植入,活体,死胎,再吸收以及外部,骨骼和内脏异常的发生方式与对照组没有差异。处理小鼠的骨髓细胞中的染色体畸变数与阴性对照组没有显着差异。与对照组相比,微核试验显示微核的频率没有升高。在两种较高剂量的Pipethiadene和Pizotifen马来酸盐后,有丝分裂指数低于对照组[3]。 |
参考文献 |
密度 | 1.2±0.1 g/cm3 |
---|---|
沸点 | 436.7±45.0 °C at 760 mmHg |
熔点 | 140-142°C |
分子式 | C19H21NS |
分子量 | 295.442 |
闪点 | 217.9±28.7 °C |
精确质量 | 295.139465 |
PSA | 31.48000 |
LogP | 6.13 |
外观性状 | 固体;White to Almost white powder to crystal |
蒸汽压 | 0.0±1.0 mmHg at 25°C |
折射率 | 1.631 |
储存条件 | Refrigerator |
计算化学 | 1.疏水参数计算参考值(XlogP):3.8 2.氢键供体数量:0 3.氢键受体数量:2 4.可旋转化学键数量:0 5.互变异构体数量:无 6.拓扑分子极性表面积:31.5 7.重原子数量:21 8.表面电荷:0 9.复杂度:406 10.同位素原子数量:0 11.确定原子立构中心数量:0 12.不确定原子立构中心数量:0 13.确定化学键立构中心数量:0 14.不确定化学键立构中心数量:0 15.共价键单元数量:1 |
Method development for impurity profiling in SFC: The selection of a dissimilar set of stationary phases.
J. Pharm. Biomed. Anal. 111 , 333-43, (2015) Supercritical fluid chromatography (SFC) is drawing considerable interest as separation technique in the pharmaceutical industry. The technique is already well established in chiral separations both a... |
|
Efficacy of amitriptyline, pizotifen and propranolol in the prevention of migraine.
Mymensingh Med. J. 22(1) , 93-100, (2013) This intervention study conducted in the Neurology outpatient Department of Mymensingh Medical College Hospital (MMCH) from January 2006 to December 2007 to compare efficacy of amitriptyline, pizotife... |
|
Potential vascular alpha1-adrenoceptor blocking properties of an array of 5-HT receptor ligands in the rat.
Eur. J. Pharmacol. 535(1-3) , 234-42, (2006) This study set out to analyse the potential ability of some 5-hydroxytryptamine (5-HT) receptor ligands widely used in cardiovascular experimental models to interact with vascular alpha1-adrenoceptors... |
4-(1-Methyl-4-piperidylidene)-9,10-dihydro-4H-benzo[4,5]cyclohepta[1,2-b]thiophene |
4-(9,10-Dihydro-4H-benzo[4,5]cyclohepta[1,2-b]thiophen-4-ylidene)-1-methylpiperidine |
UNII:0BY8440V3N |
Piperidine, 4-(9,10-dihydro-4H-benzo[4,5]cyclohepta[1,2-b]thien-4-ylidene)-1-methyl- |
Pizotyline |
EINECS 239-632-9 |
Piperidine, 4-(9,10-dihydro-4H-benzo(4,5)cyclohepta(1,2-b)thien-4-ylidene)-1-methyl- |
Pizotifen |
Sandomigran |
4-(4,5-dihydrobenzo[1,2]cyclohepta[3,4-b]thiophen-10-ylidene)-1-methylpiperidine |
4-(9,10-Dihydro-4H-benzo[4,5]cyclohepta[1,2-b]thien-4-ylidene)-1-methylpiperidine |
MFCD00864192 |